Annual Financial Report & Accounts 2024

GSK Capital B.V.

27 June 2025

 

Issued: 27 June 2025, London UK

GSK Capital B.V. publication of 2024 Annual Report & Financial Statements

 

Today, 27 June 2025, GSK Capital B.V. (the "Company") published on the GSK Group ("GSK") website, www.gsk.com*, its Annual Report and Financial Statements in respect of the year ended 31 December 2024.

In compliance with Listing Rule 9.6.1 of the UK Financial Conduct Authority ("FCA"), copies of the Company's 2024 Annual Report and Financial Statements, have been submitted to the FCA's National Storage Mechanism (NSM) submission portal via Electronic Submission System (ESS). The Company is using the exemption available to it under the Disclosure and Transparency Rules 6.3.5(1A) and is not setting out the full text of the regulated information in this announcement and has instead made the regulated information available in unedited full text on the NSM.

A copy can be viewed at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

V A Whyte

GSK plc Company Secretary

27 June 2025

* https://www.gsk.com/en-gb/company/codes-standards-and-reports/#gsk-capital-plc-annual-reports

Cautionary statement regarding forward-looking statements

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q1 Results for 2025.

Registered in England & Wales:

No. FC038264

      BR023357

UK establishment office address:

79 New Oxford Street

London

WC1A 1DG

 

END